CRISPR Therapeutics and ViaCyte, Inc. to Start Clinical Trial of the First Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes
-Initiation of patient enrollment expected by year-end- ZUG, Switzerland and CAMBRIDGE, Mass. and SAN DIEGO,…
Dynamic Expands to Loudoun County, Virginia — Meeting Customer Demand for Secure, Sustainable ITAD and Data Center Services in “Data Center Alley”
Prompt Infrastructure as the New Battleground for AI Assistants
Building Real Software Supply Chain Resilience in a Time of Rising Pressure